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expected to have a higher incidence of associated de- can be explained with physiological reasoning of cate-
cholamine-induced renal vasoconstriction leading to acutelayed graft function and poorer graft outcome. Further-
more, catecholamines can cause renal vasoconstriction tubular necrosis, as emphasized by Geddes et al. The lower
incidence in biopsy-proven rejections after catecholamineand lead to acute tubular necrosis.
Without addressing these issues, we feel that a ran- use remains a new and unexpected observation.
We agree that further information on accurate cate-domized trial to compare catecholamines to no catechol-
amines in potential kidney donors is not justifiable. cholamine dosage, duration of treatment, etc., is war-
ranted before a randomized trial is to be justified. How-However, a prospective study examining the same fac-
tors as Schnuelle et al but with accurate documentation ever, lack of these data does not in principle jeopardize
the methods and outcome of the current study.of catecholamine dose, duration, and time-averaged
blood pressure would provide valuable information, and Peter Schnuelle and Fokko J. van der Woude
Mannheim, Germanycould be carried out in a relatively short period.
Colin C. Geddes, G.V. Ramesh Prasad, Lalit Agarwal,
Heather Reich, Charles Wei, and Edward H. Cole
The Toronto Hospital and University of Toronto
Toronto, Ontario, Canada
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To the Editor: The study by Eppel et al presents surpris-
ing new data on the glomerular filtration of albumin and
subsequent tubular reabsorption of intact albumin back
to the circulation in rat kidney [1]. From their Table 4,
the concentration of albumin in the glomerular ultrafil-Reply from the authors
trate can be calculated to be 2.3 mg/mL. Previous reported
Geddes et al raised criticisms regarding the methodol- values in rat and dog have varied between ,0.001 and
ogy of our study. Firstly, as mentioned in our study, the 0.05 mg/mL (reviewed in [2]). The value presented by
beneficial effect of donor catecholamine use on acute Eppel et al is thus a factor 45 higher than the highest
rejection after transplantation was clearly confirmed by concentrations reported. Based on their experiments the
univariate analysis, which argues against a chance associa- authors suggest a high capacity cellular reabsorption
tion due to statistical overfitting of the multivariate model. mechanism in the very early part of the proximal tubule,
Secondly, treated and non-treated donors did not dif- providing an explanation why previous micropuncture
fer with respect to blood pressure, serum creatinine, and studies did not find the high concentration of albumin
urine production before removal of the kidneys. Taking suggested by this study. The authors furthermore suggest
into consideration that the data on vasopressor employ- that the reabsorption is transcellular. However, immuno-
ment to the donor reflect multicenter experience in the histochemistry for endogenous albumin in the initial part
Eurotransplant area does not support uniform confound- of rat proximal tubule (Fig. 1A), reveals no difference in
ing by indication. Geddes et al suspect that the results the intracellular concentration of albumin as compared
could be biased in favor of catecholamine use, if vaso- to later parts of segment 1 of the proximal tubule. Further-
pressors were preferentially given to donors without he- more, there is no evidence to suggest a transtubular trans-
modynamic compromise and vice versa withheld from port of intact albumin, neither at the light microscope level
hypotensive donors, thereby causing an adverse out- nor at the electron microscope level (Fig. 1B). Albumin is
come, which is quite unusual in a clinical setting. More- always localized either in apical endosomes or in lyso-
over, this view is unlikely to be true, since there was a somes as shown by double labeling for albumin and ca-
significant association between donor noradrenaline use thepsin B. A possible explanation for the results presented
and delayed graft function in our study. This observation by Eppel et al is that the injected, probably in part dena-
tured albumin, binds to the basolateral membrane of the
tubules followed by a subsequent slow release simulating
a transtubular transport of intact albumin. This mode ofÓ 2000 by the International Society of Nephrology
